OLMA – olema pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at Citigroup Inc. from $21.00 to $60.00. They now have a "buy" rating on the stock.
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $45.00 to $48.00. They now have an "outperform" rating on the stock.
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $26.00 to $38.00. They now have a "buy" rating on the stock.
Olema (OLMA) Hits 4-Year High as Jefferies Hikes PT [Yahoo! Finance]
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at HC Wainwright from $36.00 to $45.00. They now have a "buy" rating on the stock.
Form S-3ASR Olema Pharmaceuticals,
Form 4 Olema Pharmaceuticals, For: Dec 08 Filed by: Kovacs Shane William Charles
Form 4 Olema Pharmaceuticals, For: Nov 26 Filed by: Kovacs Shane William Charles
Form 4 Olema Pharmaceuticals, For: Nov 21 Filed by: RAPPAPORT ANDREW
Form 8-K Olema Pharmaceuticals, For: Nov 19
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.